
America’s Last Line of Defense for a Safe Vaccine
The independent advisers to the CDC and FDA will not bend to politics
The independent advisers to the CDC and FDA will not bend to politics
Here are pandemic highlights for the week
A vaccine made by Pfizer could seek emergency approval by the third week of November, but it likely won’t be available to the public until mid- to late 2021
Nirav Shah directs Maine’s response, which is seeing impressive results despite risk factors
Epidemiologists offer tips for U.S. voters and poll workers to limit their chances of getting infected
From a human-made virus to vaccine conspiracy theories, we rounded up the most insidious false claims about the pandemic
It’s not just “antiscience thinking”
Synthetic peptides that mimic human antibodies for COVID-19 could be cheaper and easier to produce
This “infodemic” has to stop
A stretch of Neandertal DNA has been associated with some cases of severe COVID-19, but it’s unclear how much of a risk it poses. Christopher Intagliata reports.
The pandemic offers colleges and universities an unexpected opportunity to reinvent themselves in ways that better serve students and faculty
Here are pandemic news highlights for the week
China has promised vaccines to many countries, but whether it can meet its commitments is unclear
Doctors say the president could be heading for a bad stretch in prolonged illness—or an upward path to recovery
It kills more people than the flu, contrary to Trump’s claims, and also surpasses stroke, Alzheimer’s and diabetes
An expert on airborne virus transmission explains the risks of talking loudly without wearing a mask in an indoor environment
Researchers are exploring ways to use people’s vocalizations to diagnose coronavirus infections, dementia and depression
This pandemic is far from over, and we aren’t doing enough to stop it
A noted bioethicist says the president’s case could trigger calls for greater transparency about his health—and spawn conspiracy theories
Here are pandemic highlights for the week
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account